Filing Details

Accession Number:
0001140361-14-016105
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-04-08 17:57:57
Reporting Period:
2014-04-08
Filing Date:
2014-04-08
Accepted Time:
2014-04-08 17:57:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1594337 Corium International Inc. CORI Pharmaceutical Preparations (2834) 383230774
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1597585 W Ronald Eastman C/O Essex Woodlands Health Ventures
335 Bryant Street, Third Floor
Palo Alto CA 94301
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-04-08 679,115 $0.00 679,115 No 4 C Indirect See footnote
Common Stock Acquisiton 2014-04-08 2,028,309 $0.00 2,707,424 No 4 C Indirect See footnote
Common Stock Acquisiton 2014-04-08 397,718 $0.00 3,105,142 No 4 X Indirect See footnote
Common Stock Acquisiton 2014-04-08 26,385 $0.00 3,131,527 No 4 X Indirect See footnote
Common Stock Acquisiton 2014-04-08 214,149 $0.00 3,345,676 No 4 X Indirect See footnote
Common Stock Acquisiton 2014-04-08 1,114 $0.00 3,346,790 No 4 X Indirect See footnote
Common Stock Acquisiton 2014-04-08 218,279 $0.00 3,565,069 No 4 X Indirect See footnote
Common Stock Acquisiton 2014-04-08 794 $0.00 3,565,863 No 4 X Indirect See footnote
Common Stock Acquisiton 2014-04-08 397 $0.00 3,566,260 No 4 X Indirect See footnote
Common Stock Acquisiton 2014-04-08 3,387,146 $0.00 6,953,406 No 4 C Indirect See footnote
Common Stock Acquisiton 2014-04-08 1,999,898 $0.00 8,953,304 No 4 C Indirect See footnote
Common Stock Acquisiton 2014-04-08 400,000 $8.00 9,353,304 No 4 P Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect See footnote
No 4 C Indirect See footnote
No 4 X Indirect See footnote
No 4 X Indirect See footnote
No 4 X Indirect See footnote
No 4 X Indirect See footnote
No 4 X Indirect See footnote
No 4 X Indirect See footnote
No 4 X Indirect See footnote
No 4 C Indirect See footnote
No 4 C Indirect See footnote
No 4 P Indirect See footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series B Convertible Preferred Stock Disposition 2014-04-08 6,859,066 $0.00 679,115 $0.00
Common Stock Series C Convertible Preferred Stock Disposition 2014-04-08 20,485,926 $0.00 2,028,309 $0.00
Common Stock Warrant to Purchase Common Stock Disposition 2014-04-08 397,718 $0.00 397,718 $0.00
Common Stock Warrant to Purchase Common Stock Disposition 2014-04-08 26,385 $0.00 26,385 $0.00
Common Stock Warrant to Purchase Common Stock Disposition 2014-04-08 214,149 $0.00 214,149 $0.00
Common Stock Warrant to Purchase Common Stock Disposition 2014-04-08 1,114 $0.00 1,114 $0.00
Common Stock Warrant to Purchase Common Stock Disposition 2014-04-08 218,279 $0.00 218,279 $0.00
Common Stock Warrant to Purchase Series C Convertible Preferred Stock Disposition 2014-04-08 109,015 $0.00 794 $0.00
Common Stock Warrant to Purchase Series C Convertible Preferred Stock Disposition 2014-04-08 54,507 $0.00 397 $0.00
Common Stock Convertible Promissory Notes Disposition 2014-04-08 3,387,146 $0.00 3,387,146 $0.00
Common Stock Convertible Promissory Notes Disposition 2014-04-08 1,999,898 $0.00 1,999,898 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
0 2017-08-02 No 4 X Indirect
0 2017-08-02 No 4 X Indirect
0 2017-08-02 No 4 X Indirect
0 2017-08-02 No 4 X Indirect
0 2017-08-02 No 4 X Indirect
0 2020-07-02 No 4 X Indirect
0 2020-12-29 No 4 X Indirect
0 2017-07-01 No 4 C Indirect
0 2017-07-01 No 4 C Indirect
Footnotes
  1. The shares of Series B Convertible Preferred Stock and Series C Convertible Preferred Stock automatically converted into Common Stock in connection with the Issuer's initial public offering and had no expiration date.
  2. The number of shares reflects a 10.1-for-1 reverse stock spilt of all outstanding shares of Common Stock effected on March 21, 2014.
  3. The securities are held of record by Essex Woodlands Health Ventures Fund VII, L.P. (the "Fund"). The Reporting Person may be deemed to share voting and investment power over securities held by the Fund.
  4. The warrants were automatically net exercised in connection with the Issuer's initial public offering at an exercise price of $2.12100 per share.
  5. The warrants were automatically net exercised in connection with the Issuer's initial public offering at an exercise price of $7.41140 per share.
  6. The principal amount and accrued interest automatically converted into the specified number of shares of Common Stock in connection with the Issuer's initial public offering.